{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:19:10Z","timestamp":1789744750389,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.phrs.2017.05.024","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T17:01:18Z","timestamp":1496077278000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases"],"prefix":"10.1016","volume":"127","author":[{"given":"Ricardo","family":"Sanz-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fern\u00e1ndez-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.phrs.2017.05.024_bib0005","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe\u2013epidemiologicalupdate 2015","author":"Townsend","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.05.024_bib0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tcm.2016.01.003","article-title":"Stem cell therapy for heart failure: ensuring regenerative proficiency","volume":"26","author":"Terzic","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2017.05.024_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4252\/wjsc.v7.i2.352","article-title":"Second-generation stem cells for cardiac repair","volume":"7","author":"Nunez Garcia","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.phrs.2017.05.024_bib0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0035","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/eurheartj\/ehw113","article-title":"Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure","volume":"37","author":"Madonna","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.05.024_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.scr.2014.04.008","article-title":"The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult","volume":"13","author":"Nadal-Ginard","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2017.05.024_bib0050","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCULATIONAHA.112.118380","article-title":"Cardiomyogenesis in the aging and failing human heart","volume":"126","author":"Kajstura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/emmm.201201737","article-title":"Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart","volume":"5","author":"Malliaras","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2017.05.024_bib0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00018-007-6519-y","article-title":"Resident cardiac stem cells","volume":"64","author":"Torella","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2017.05.024_bib0065","first-page":"641","article-title":"Cardiac stem and progenitor cell identification: different markers for the same cell?","volume":"2","author":"Ellison","year":"2010","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"10.1016\/j.phrs.2017.05.024_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/heartjnl-2011-300639","article-title":"Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms","volume":"98","author":"Ellison","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2017.05.024_bib0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2017.05.024_bib0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.0000053618.86362.DF","article-title":"Myocyte death, growth, and regeneration in cardiac hypertrophy and failure","volume":"92","author":"Nadal-Ginard","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cell.2013.07.039","article-title":"Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair","volume":"154","author":"Ellison","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2017.05.024_bib0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0095","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/14779072.2015.1011621","article-title":"Allogeneic cardiac stem cell administration for acute myocardial infarction","volume":"13","author":"Crisostomo","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2017.05.024_bib0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.yjmcc.2010.06.010","article-title":"Cardiac cell therapy: lessons from clinical trials","volume":"50","author":"Menasche","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/tan.12614","article-title":"Allogenic benefit in stem cell therapy: cardiac repair and regeneration","volume":"86","author":"Al-Daccak","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.phrs.2017.05.024_bib0115","doi-asserted-by":"crossref","first-page":"41125","DOI":"10.1038\/srep41125","article-title":"Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem\/progenitor cells","volume":"7","author":"Hocine","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2017.05.024_bib0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCRESAHA.112.276501","article-title":"Allogenicity of human cardiac stem\/progenitor cells orchestrated by programmed death ligand 1","volume":"112","author":"Lauden","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvu208","article-title":"Natural killer cell crosstalk with allogeneic human cardiac-derived stem\/progenitor cells controls persistence","volume":"104","author":"Boukouaci","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0130","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/CIRCULATIONAHA.110.955971","article-title":"Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair","volume":"122","author":"Huang","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCULATIONAHA.111.042598","article-title":"Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells","volume":"125","author":"Malliaras","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","article-title":"Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies","volume":"116","author":"Jansen Of Lorkeers","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0145","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2012.10.052","article-title":"Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains","volume":"61","author":"Tseliou","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCHEARTFAILURE.112.972273","article-title":"Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction","volume":"6","author":"Welt","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2017.05.024_bib0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0170","doi-asserted-by":"crossref","first-page":"e113805","DOI":"10.1371\/journal.pone.0113805","article-title":"Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy","volume":"9","author":"Yee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.05.024_bib0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.112.001075","article-title":"Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy","volume":"128","author":"Bolli","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0180","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/CIRCULATIONAHA.113.002863","article-title":"Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction","volume":"128","author":"Malliaras","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-015-0512-2","article-title":"Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine","volume":"13","author":"Crisostomo","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2017.05.024_bib0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCHEARTFAILURE.114.001484","article-title":"Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction","volume":"8","author":"Kanazawa","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2017.05.024_bib0195","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.05.024_bib0200","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.05.024_bib0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0215","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.jacc.2008.06.052","article-title":"Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction","volume":"52","author":"Takehara","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096368916X692933","article-title":"ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design","volume":"26","author":"Chakravarty","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phrs.2017.05.024_bib0225","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ejhf.434","article-title":"Congestive heart failure cardiopoietic regenerative therapy (CHART-1) trial design","volume":"18","author":"Bartunek","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2017.05.024_bib0235","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw543","article-title":"Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","author":"Bartunek","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.05.024_bib0240","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","article-title":"Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy","volume":"66","author":"Karantalis","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.024_bib0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","article-title":"Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction","volume":"127","author":"Williams","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.024_bib0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/CIRCRESAHA.116.309782","article-title":"A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells","volume":"120","author":"Sharma","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0255","first-page":"201","article-title":"Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction","volume":"38","author":"Gallet","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.05.024_bib0260","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","article-title":"Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy","volume":"119","author":"Tokita","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.05.024_bib0265","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.healun.2016.05.008","article-title":"Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction","volume":"35","author":"Reich","year":"2016","journal-title":"J. Heart Lung Transplant."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817303973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817303973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T11:34:53Z","timestamp":1535801693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817303973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":53,"alternative-id":["S1043661817303973"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.05.024","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}